Dynamic Capital Management Ltd Reduces Stake in DaVita HealthCare Partners Inc. (DVA)

Dynamic Capital Management Ltd reduced its position in DaVita HealthCare Partners Inc. (NYSE:DVA) by 28.4% during the first quarter, Holdings Channel reports. The institutional investor owned 22,812 shares of the company’s stock after selling 9,064 shares during the period. Dynamic Capital Management Ltd’s holdings in DaVita HealthCare Partners were worth $1,551,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of the company. Pacer Advisors Inc. boosted its stake in shares of DaVita HealthCare Partners by 3.0% in the first quarter. Pacer Advisors Inc. now owns 3,422 shares of the company’s stock worth $233,000 after buying an additional 101 shares in the last quarter. Wetherby Asset Management Inc. boosted its stake in shares of DaVita HealthCare Partners by 3.3% in the first quarter. Wetherby Asset Management Inc. now owns 3,224 shares of the company’s stock worth $219,000 after buying an additional 104 shares in the last quarter. SRS Capital Advisors Inc. boosted its stake in shares of DaVita HealthCare Partners by 6.6% in the first quarter. SRS Capital Advisors Inc. now owns 1,966 shares of the company’s stock worth $133,000 after buying an additional 122 shares in the last quarter. Mycio Wealth Partners LLC boosted its stake in shares of DaVita HealthCare Partners by 0.5% in the first quarter. Mycio Wealth Partners LLC now owns 24,581 shares of the company’s stock worth $1,671,000 after buying an additional 125 shares in the last quarter. Finally, Thrivent Financial For Lutherans raised its position in shares of DaVita HealthCare Partners by 4.4% in the first quarter. Thrivent Financial For Lutherans now owns 5,730 shares of the company’s stock worth $389,000 after buying an additional 240 shares during the last quarter. 82.46% of the stock is currently owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for DaVita HealthCare Partners (NYSE:DVA)

DaVita HealthCare Partners Inc. (NYSE DVA) traded down 1.62% during midday trading on Tuesday, hitting $64.98. The stock had a trading volume of 771,636 shares. The firm has a 50-day moving average of $65.63 and a 200 day moving average of $66.11. DaVita HealthCare Partners Inc. has a 52-week low of $54.50 and a 52-week high of $78.77. The firm has a market capitalization of $12.65 billion, a P/E ratio of 10.67 and a beta of 1.00.

DaVita HealthCare Partners (NYSE:DVA) last issued its earnings results on Tuesday, May 2nd. The company reported $0.79 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.82 by $0.03. DaVita HealthCare Partners had a return on equity of 14.85% and a net margin of 8.28%. The business had revenue of $3.70 billion for the quarter, compared to analysts’ expectations of $3.69 billion. On average, equities analysts forecast that DaVita HealthCare Partners Inc. will post $3.54 EPS for the current year.

TRADEMARK VIOLATION WARNING: This report was reported by Ticker Report and is the property of of Ticker Report. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be viewed at https://www.tickerreport.com/banking-finance/2656268/dynamic-capital-management-ltd-reduces-stake-in-davita-healthcare-partners-inc-dva.html.

A number of brokerages recently weighed in on DVA. Jefferies Group LLC set a $70.00 price objective on shares of DaVita HealthCare Partners and gave the stock a “buy” rating in a report on Friday, May 26th. Goldman Sachs Group, Inc. (The) restated a “sell” rating and issued a $62.00 price objective on shares of DaVita HealthCare Partners in a report on Thursday, May 25th. Zacks Investment Research lowered shares of DaVita HealthCare Partners from a “buy” rating to a “hold” rating in a report on Wednesday, April 19th. Finally, TheStreet upgraded shares of DaVita HealthCare Partners from a “c+” rating to a “b-” rating in a report on Monday, April 3rd. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $69.50.

In other news, Director William L. Roper sold 12,994 shares of DaVita HealthCare Partners stock in a transaction dated Thursday, May 4th. The shares were sold at an average price of $65.89, for a total value of $856,174.66. Following the sale, the director now owns 45,277 shares in the company, valued at $2,983,301.53. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Charles Berg sold 8,414 shares of DaVita HealthCare Partners stock in a transaction dated Tuesday, May 9th. The shares were sold at an average price of $65.80, for a total transaction of $553,641.20. Following the completion of the sale, the director now owns 34,719 shares in the company, valued at approximately $2,284,510.20. The disclosure for this sale can be found here. In the last quarter, insiders sold 22,702 shares of company stock worth $1,495,492. Company insiders own 2.00% of the company’s stock.

DaVita HealthCare Partners Company Profile

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “DVA”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita HealthCare Partners Inc. (NYSE:DVA).

Receive News & Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
President Trump Hurting Tourism in the U.S.
President Trump Hurting Tourism in the U.S.
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.